Vaccines for children coming soon, but how do we keep schools safe?
On September 20th, 2021, Pfizer-BioNtech announced preliminary results from its phase 2/3 trial in children ages 5 to 11 with a two-dose vaccine scheme.
COVID-19 vaccine effectiveness against hospitalization and emergency department visits: a comparison
COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to several recent publications.
Humoral immunity to seasonal coronaviruses may be associated with better outcomes in COVID-19
People infected with SARS-CoV-2 can experience a wide range of outcomes, ranging from asymptomatic infection to severe disease and death.
Increase in SARS-CoV-2 Seroprevalence in the U.S. from July 2020 to May 2021
The proportion of people in the U.S. with SARS-CoV-2 antibodies remains uncertain. A new study published in JAMA used a sample of 1.44 million blood samples from July 2020 through May 2021 to estimate the SARS-CoV-2 seroprevalence in the general US population aged 16 years and older.
The two new SARS-CoV-2 variants scientists are tracking
The World Health Organization (WHO) has recently introduced a new Variant of Interest (VOI) titled Mu or B.1.621.
Review of host factors highjacked by SARS-CoV-2
A recent state-of-the-art review in Nature Microbiology summarizes the latest evidence regarding the molecules in our cells that allow SARS-CoV-2 to infect us and how these may give us clues to discover new anti-viral drugs.
Concerns about legal challenges to COVID-19 public health orders
The field of public health has never been without critics. Globally, public health officers wield varying amounts of power, with the North American court systems historically respecting and upholding public health order.
Outcomes of COVID-19 in children and adolescents with cancer
Previous studies have shown that children with COVID-19 generally have a milder disease course compared to adults.
Delta doubles risk of hospitalization compared to Alpha, study finds
New research out of England published in The Lancet Infectious Diseases suggests that hospitalization and visits to the emergency department are twice as likely with the variant of concern (VOC) Delta compared to the Alpha variant.